Breast cancer is more commonly diagnosed and is now the second leading cause of cancer death after lung cancer as the most common invasive form in women It has surpassed lung cancer as the leading cause of global cancer incidence in with an estimated million new cases representing of all cancer cases The deadly virus Covid which became a global pandemic in the year has affected every aspect of life including screening diagnosis and treatment of other diseases People with cancer especially have found themselves in a difficult and frightening situation ever since the pandemic began Covid has since been associated with multi organ failure due to immune mediated damage Immune compromised people such as cancer patients are not only at increased risk of SARS CoV infection but also of severe infection and poor prognosis or fatality So many people have been found delaying the screening and treatments A recent report published by National Cancer Registry Programme NCRP estimates that the number of cancer cases is likely to increase from lakh in to lakh by an increase of nearly Covid has impacted breast cancer patients by not only increasing the chances of infection but also on the treatment associated with breast cancer Adjuvant therapies are delivered after the primary treatment to destroy remaining cancer cells Systemic adjuvant or neoadjuvant therapies including chemotherapies have been shown to be related with an increased risk of severe SARS CoV infection sequelae When appropriate duration of treatment should be shortened to decrease the number of hospital visits but in other instances treatment duration should be maintained to avoid increasing the risk of immunosuppression depending on the clinical condition of patients Conventional adjuvant neoadjuvant systemic medications such as anti human epidermal growth factor receptor and endocrine therapy have historically not been related with problems of COVID and hence should be used according to the guidelines Read more 